Truveta news For media inquiries, please email news@truveta.com Truveta expands its community to more than 40 healthcare and life science organizations May 17, 2023 Truveta collaboration with Harvard University researchers published in JAMA Network Open May 11, 2023 Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena,… Revolutionizing patient care with AI in healthcare: How Truveta leverages data and AI to make a difference April 20, 2023 Truveta Language Model unlocks EHR data for the most complete and accurate medical research April 12, 2023 Partnership announced between Truveta and Alpine Immune Sciences March 22, 2023 Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being… New SDOH data in Truveta Studio March 1, 2023 LinkedIn Live: Truveta Research discusses recent maternal heart health study February 15, 2023 The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color… Truveta partners honored as Modern Healthcare’s 100 Most Influential December 7, 2022 We’re proud to share that leaders from a number of our health system members have been named as Modern Healthcare’s 100 Most Influential People In Healthcare… « Previous 1 … 7 8 9 … 11 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors December 4, 2023 Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss November 27, 2023 Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research November 8, 2023 More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI October 23, 2023 See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
Truveta collaboration with Harvard University researchers published in JAMA Network Open May 11, 2023 Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena,…
Revolutionizing patient care with AI in healthcare: How Truveta leverages data and AI to make a difference April 20, 2023
Truveta Language Model unlocks EHR data for the most complete and accurate medical research April 12, 2023
Partnership announced between Truveta and Alpine Immune Sciences March 22, 2023 Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being…
LinkedIn Live: Truveta Research discusses recent maternal heart health study February 15, 2023 The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color…
Truveta partners honored as Modern Healthcare’s 100 Most Influential December 7, 2022 We’re proud to share that leaders from a number of our health system members have been named as Modern Healthcare’s 100 Most Influential People In Healthcare…
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors December 4, 2023
Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss November 27, 2023
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research November 8, 2023
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI October 23, 2023